Gara Jalqabaatti › Myelodysplastic Syndromes › Florida › Tampa
Qorannoo klinikaalii Myelodysplastic Syndromes Tampa, FL keessatti
Qorannoo 19 Myelodysplastic Syndromes f Tampa fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
Namoota walitti qabaa jiraSadarkaa 1/2
- Moffitt Cancer Center, Tampa
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Namoota walitti qabaa jiraSadarkaa 3
- Moffitt Cancer Center, Tampa
A Study of BGB-11417 in Participants With Myeloid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Tampa General Hospital, Tampa
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Namoota walitti qabaa jiraSadarkaa 1/2
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Namoota walitti qabaa jiraSadarkaa 3
- Moffitt Cancer Center, Tampa
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
Namoota walitti qabaa jiraSadarkaa 2
- H. Lee Moffitt Cancer Center and Research Center, Tampa
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- H Lee Moffitt Cancer Center & Research Institute, Tampa
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
- Moffitt Cancer Center, Tampa
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Namoota walitti qabaa jiraSadarkaa 1/2
- Moffitt Cancer Center, Tampa
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Namoota walitti qabaa jiraSadarkaa 2
- Moffitt Cancer Center, Tampa
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
Study of SX-682 Alone and in Combination With Oral or Intravenous Decitabine in Subjects With Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Tampa
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
Study of REM-422 in Patients With AML or Higher Risk MDS
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
Namoota walitti qabaa jiraSadarkaa 1/2
- H. Lee Moffitt Cancer Center & Research Institute, Tampa
Qorannoo Myelodysplastic Syndromes magaalota biroo keessatti
- Houston, TXQorannoo 43
- Baldwin Park, CAQorannoo 26
- New York City, NYQorannoo 21
- Seattle, WAQorannoo 21
- Washington, DCQorannoo 20
- Boston, MAQorannoo 19
- Miami, FLQorannoo 17
- Durham, NCQorannoo 14
- Columbus, OHQorannoo 14
- St. Louis, MOQorannoo 13
- Atlanta, GAQorannoo 13
- Chicago, ILQorannoo 13
Qorannoo biroo Tampa keessatti
- Kansara Qara'a Non-Small CellQorannoo 51
- Saree OljooQorannoo 43
- Saree (Gosoota Hunda)Qorannoo 39
- Kansarii ColorectalQorannoo 34
- Leukemia Myeloidii HamaaQorannoo 29
- Kansara MetastatikiiQorannoo 29
- Dhibee QaraQorannoo 29
- Kansarii PancreasQorannoo 26
- Kansarii OvariiQorannoo 21
- MelanomaQorannoo 19
- Kansarii ProstateQorannoo 18
- Cufama OnneeQorannoo 18
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.